Prognostic role of p53 in stage III non-small cell lung cancer.

Journal

Anticancer research

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MASCAUX Céline

Tous les auteurs :
Berghmans T, Mascaux C, Martin B, Ninane V, Sculier JP

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/16080465

Résumé

New biological factors have not been extensively studied in stage III non-small cell lung cancer (NSCLC). We aimed to determine the role of p53 as a prognostic factor in such patients.

Mots clés

Adult, Aged, Aged, 80 and over, Biomarkers, Tumor, biosynthesis, Carcinoma, Non-Small-Cell Lung, metabolism, Combined Modality Therapy, Female, Humans, Immunohistochemistry, Lung Neoplasms, metabolism, Male, Middle Aged, Neoplasm Staging, Prognosis, Proportional Hazards Models, Tumor Suppressor Protein p53, biosynthesis

Référence

Anticancer Res.. ;25(3c):2385-9